Senile plaques with amyloid-beta (Aβ) peptides in the extracellular milieu, neurofibrillary tangles encompassing tau proteins, and synapse dysfunction and the associated neuronal loss are the key pathognomonic of AD [1]. This evidence concerns the gene MAPT and Alzheimer disease.